Essa Pharma Stock Investor Sentiment
| EPIX Stock | USD 1.79 0.02 1.10% |
Slightly above 75% of ESSA Pharma's investor base is looking to short. The analysis of the overall investor sentiment regarding ESSA Pharma suggests that many traders are alarmed. ESSA Pharma's investing sentiment can be driven by a variety of factors including economic data, ESSA Pharma's earnings reports, geopolitical events, and overall market trends.
ESSA |
ESSA Pharma Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards ESSA Pharma can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Far too much social signal, news, headlines, and media speculation about ESSA Pharma that are available to investors today. That information is available publicly through ESSA media outlets and privately through word of mouth or via ESSA internal channels. However, regardless of the origin, that massive amount of ESSA data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of ESSA Pharma news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of ESSA Pharma relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to ESSA Pharma's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive ESSA Pharma alpha.
ESSA Pharma Performance against Dow Jones
Price Growth (%) |
| Timeline |
1 | Disposition of tradable shares by Biotech Growth N V of ESSA Pharma subject to Rule 16b-3 | 09/05/2024 |
2 | Disposition of 694 shares by Virsik Peter of ESSA Pharma at 6.0 subject to Rule 16b-3 | 09/09/2024 |
3 | ESSA Pharma Presents Updated Phase 12 Masofaniten Clinical Data at the 2024 ESMO Congress | 09/13/2024 |
4 | EPIX Masofaniten Combination Therapy with Enzalutamide Increases rPFS Increasing Valuation to 33 per Share | 09/24/2024 |
5 | Essa Pharma COO sells shares worth over 4,000 | 10/07/2024 |
6 | Disposition of 50000 shares by Berger Franklin M of ESSA Pharma at 2.67 subject to Rule 16b-3 | 10/18/2024 |
7 | ESSA Pharma Insiders Placed Bullish Bets Worth US709.0k | 10/28/2024 |
8 | ESSA Pharma tanks after terminating trial for its prostate cancer treatment | 11/01/2024 |
9 | Bb biotech ag sells Essa Pharma shares for 12 million | 11/05/2024 |
10 | EPIX ALERT Levi Korsinsky Reminds Investors of an Investigation Involving Possible Securities Fraud Violations by ESSA Pharma Inc. | 11/14/2024 |
11 | EPIX ACTIVE INVESTIGATION Contact Levi Korsinsky if you lost money on your ESSA Pharma Inc. investment | 11/18/2024 |
12 | Acquisition by Parkinson David Ross of 350000 shares of ESSA Pharma at 9.04 subject to Rule 16b-3 | 11/27/2024 |
Additional Tools for ESSA Stock Analysis
When running ESSA Pharma's price analysis, check to measure ESSA Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ESSA Pharma is operating at the current time. Most of ESSA Pharma's value examination focuses on studying past and present price action to predict the probability of ESSA Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ESSA Pharma's price. Additionally, you may evaluate how the addition of ESSA Pharma to your portfolios can decrease your overall portfolio volatility.